Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-26

FDA Approved: GEMCITABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' supplemental application for gemcitabine hydrochloride (gemcitabine), enabling continued production and distribution …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

SUPPL AP for GEMCITABINE (GEMCITABINE HYDROCHLORIDE)